2:30 Registration

3:00 Resident/Fellow Case Presentations

4:00 Neuro-oph and Oculoplastics talks

• The Evolving Therapeutic Landscape of Thyroid Eye Disease - Ali Mokhtarzadeh, MD
• Systemic Steroids in Neuro-Ophthalmology: Who, When, and How - Michael Lee, MD
• Tarsoconjunctival Flaps - A Brief History and Novel Applications - Jeremiah Tao, MD
• Refuting an Oxymoron: Functional Can Be Fun - Collin McClelland, MD
• Eyelid and Cornea - Friend or Foe - Andrew Harrison, MD
• Avoiding Disaster in Oculofacial Plastic Surgery - Jeremiah Tao, MD

6:00 MAO Social Hour

7:00 Dinner

8:00 Wirtschafter Lecture Presentation: Neuro-Ophthalmic Consequences of Immune Checkpoint Inhibition : Lessons from Big Data - Lynn Gordon, MD

Lynn Gordon, MD

UCLA Stein Eye Institute

Education

Medical Board Certification:  Ophthalmology, American Board of Ophthalmology, 1990

Fellowship:  Neuro Ophthalmology, UCLA School of Medicine, 1989

Residency:  Ophthalmology, UCLA School of Medicine, 1988

Internship:  Internal Medicine, Mt. Auburn Hospital, 1985

Degree:  MD, Harvard Medical School, 1984

Jeremiah P. Tao, MD

Specialties

Ophthalmology, Ophthalmic Plastic & Reconstructive Surgery

Clinical Interests

blepharoplasty, cosmetic facial surgery, droopy eyelids (ptosis), eyelid malposition, eyelid bag surgery, facial skin cancers, orbital disease, tear duct surgery, Thyroid eye (Graves) disease

EDUCATION:

Medical School

University of South Carolina

Internship

St. Joseph's Hospital Internal Medicine

Residency

University of South Carolina School of Medicine Ophthalmology

Fellowship

Indiana University School of Medicine Oculofacial Plastic Orbit

Educational Objectives:
Following this presentation, the participant should be able to:

1. Identify how and when to utilize systemic corticosteroids in the treatment of optic neuritis, ischemic optic neuropathy, and myasthenia gravis. 

2. Determine strategies to diagnose functional vision loss 

3. Understand the ophthalmic consequences of immune checkpoint inhibitors 

4. Understand the diagnosis and treatment of common oculoplastic disorders 

ACCREDITATION STATEMENT This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Minnesota Medical Association and University of Minnesota, Department of Ophthalmology. The Minnesota Medical Association (MMA) is accredited by the ACCME to provide continuing medical education for physicians.    

CME STATEMENT The Minnesota Medical Association designates this Regularly Scheduled Series for a maximum of 4.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Thank you to our Exhibitor:

Amgen